NCT03424213View on ClinicalTrials.gov

Race-related Alternative Splicing: Novel Targets in Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

169

Participants

Timeline

Start Date

January 30, 2018

Primary Completion Date

July 14, 2021

Study Completion Date

July 14, 2021

Conditions
Prostate Cancer
Interventions
OTHER

No interventions - retrospective data collection

No new patients will be consented to this study. Only retrospective data will be collected on prostatectomy specimens and correlated with health data

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER

NCT03424213 - Race-related Alternative Splicing: Novel Targets in Prostate Cancer | Biotech Hunter | Biotech Hunter